Hitachi Group to Reorganize Instrument
and Semiconductor Manufacturing Equipment Operations
|
--Hitachi's Instruments Group and Semiconductor Manufacturing
Equipment Group will be separated and merged with Nissei Sangyo, forming a new
company that will take over sales of Hitachi Medical's clinical testing systems,
concentrating resources -- |
|
|
Tokyo, February 22, 2001 --- Hitachi, Ltd. (TSE: 6501) and Nissei Sangyo Co.,
Ltd. (TSE: 8036) announced today they have reached an agreement under which Hitachi's
Instruments Group and Semiconductor Manufacturing Equipment Group will be separated
and merged with Nissei Sangyo on October 1. At the same time, Nissei Sangyo Co.,
Ltd. will undergo a change of name to (provisionally) Hitachi Advanced Technologies,
Ltd. The move is being done to enable management to speedily respond to market
changes in nanotechnology areas such as semiconductor manufacturing equipment
and biotechnology-related products. The formal approval of the agreement will
take place in June, at Nissei Sangyo's Ordinary General Meeting of Shareholders.
To integrate domestic and overseas sales of the
Instrument Group's clinical testing systems, Hitachi Medical Corporation's (TSE:
6910) sales operation relating to those systems will be transferred to the new
company, also on October 1.
The new company will integrate Hitachi's instruments
and semiconductor manufacturing equipment operations with Nissei Sangyo's trading
company functions, and will also take over sales of Hitachi Medical's clinical
testing systems, resulting in an integrated management system in these nanotechnology
areas that encompasses everything from development through to manufacturing, marketing
and services. This will speed up decision-making in both business sectors, increasing
management efficiency.
By concentrating resources and making effective
use of these resources, the aim of the consolidation is to strengthen market competitiveness
and create new businesses in the biotechnology and other sectors to become the
world leader in instruments and semiconductor manufacturing equipment.
In the Medium-term Business Plan the"i.e.HITACHI
Plan"announced in November 1999, Hitachi stated its intention to strategically
employ the resources of the Hitachi Group to reform itself, both qualitatively
and structurally, into the best solutions partner for its customers. Also, as
part of Hitachi's basic policy of increasing its total market value, the company
has been moving ahead with the implementation of a consolidated management system,
based on Hitachi Group based reorganizations, reappraisals and coordinations.
This consolidation is part of a Group strategy of
strengthening nanotechnology operations, which include the instruments and semiconductor
manufacturing equipment businesses, and is also based on a fundamental strategy
of further strengthening and expanding the integration of operations between Hitachi's
business groups and affiliated companies.
In response to market needs in the area of fine
patterning technology, the Instruments Group and Semiconductor Manufacturing Equipment
Group have produced numerous products for the semiconductor, materials and biotechnology
sectors, including semiconductor manufacturing, inspection and evaluation equipment,
clinical analyzers and electron microscopes. In terms of technology, Hitachi is
a world leader in the area of medical testing equipment such as automatic blood
chemistry analyzers, as well as in the areas of electron microscopes and semiconductor
manufacturing equipment, including inspection and evaluation systems for use on
semiconductor production lines. Enjoying the synergistic effect with Nissei Sangyo's
global sales strengths, those businesses have been expanding.
However, in order to stay competitive in such leading-edge
market sectors, it is also necessary to be the first to develop new technologies
and to provide customers with optimized solutions to their needs.
In the nanotechnology areas of semiconductor manufacturing
equipment and biotechnology related products, which are part of the Hitachi Group's
strengths, the aim of this latest consolidation of operations is to create a company
that is a world leader in its sector, by building an integrated system that includes
development, manufacturing, marketing, and services, and utilizing Hitachi's advanced
technology and product development capabilities, together with Nissei Sangyo's
sales capabilities and service expertise, to speedily provide solutions that are
closely matched to customers' needs.
By also integrating sales of clinical testing systems
now being conducted by Hitachi Medical Corporation, the reorganization will consolidate
the sales systems both domestic and overseas, helping the company to strengthen
its abilities to respond to its customers' needs around the world.
With the consolidation in October, the employees
of the Instruments Group, Semiconductor Manufacturing Equipment Group and related
sales departments, as well as Hitachi Medical employees engaged in sales of clinical
testing systems, will be transferred to the new company.
Following the consolidation in October, related
facilities in Japan and overseas are expected to be reorganized to strengthen
the ability of the new company to respond to the customers' needs in markets around
the world.
The consolidation makes use of the Revisions to
the Commercial Code on corporate reorganization, which come into force on April
1, 2001. Under the provisions of this stock for asset transaction, Nissei Sangyo
will issue new shares that will be allocated to Hitachi, while continues to list
its shares on stock exchanges under the new company name. The parties to the agreement
will endeavor to work out by April the number of new shares to be issued and other
such details.
|
Outline of New Company
Company Name |
: |
Hitachi Advanced Technologies,
Ltd. (provisional) |
Location |
: |
24-14 Nishishimbashi 1-chome, Minato-ku,
Tokyo |
Capital |
: |
To be decided by April |
Date of transaction |
: |
October 1, 2001 |
President |
: |
Noriaki Higuchi (provisional) |
Sales (est.): |
: |
(Consolidated) |
822 billion yen (Fiscal 2001), |
900 billion yen (Fiscal 2002) |
(Unconsolidated) |
592 billion yen (Fiscal 2001), |
656 billion yen (Fiscal 2002) |
|
Income (est.) |
: |
(Consolidated) |
10 billion yen (Fiscal 2001), |
16.5 billion yen (Fiscal 2002) |
(Unconsolidated) |
6.6 billion yen (Fiscal 2001), |
10.5 billion yen (Fiscal 2002) |
|
Employees
(est. as of Oct. 2001) |
: |
(Consolidated basis) 8,060, (Unconsolidated
basis) 3,270 |
Main business |
: |
1. |
Manufacture, sales and service of semiconductor
manufacturing, inspection and evaluation equipment, scientific equipment, medical
and biotechnological equipment, environmental systems, etc., in Japan and overseas |
2. |
Sales and service of information systems,
electronic components and advanced industrial products, etc., in Japan and overseas |
|
About Hitachi, Ltd.
Hitachi, Ltd., headquartered
in Tokyo, Japan, is one of the world's leading global electronics companies, with
fiscal 1999 (ended March 31, 2000) consolidated sales of 8,001 billion yen ($75.5
billion*). The company manufactures and markets a wide range of products,
including computers, semiconductors, consumer products and power and industrial
equipment. For more information on Hitachi, Ltd., please visit Hitachi's Web site
at http://global.hitachi.com/ . |
*At an exchange rate of 106 yen to the dollar |
About Nissei Sangyo Co., Ltd.
Nissei Sangyo Co., Ltd.
is a high-technology trading company of the Hitachi Group that is engaged in marketing
activities in a broad range of fields that include scientific equipment, semiconductor
manufacturing, testing and evaluation equipment, information systems, semiconductors,
and leading-edge materials. In recent years, Nissei Sangyo has been particularly
active in expanding business in the areas of nanotechnology and life science,
which the company regards as critically important business sectors in which it
is building up a system for development and marketing activities, introducing
important technologies from overseas, and entering into alliances with Hitachi
Group companies. |
|
Company Name |
: |
Nissei Sangyo Co., Ltd. |
Head Office |
: |
24-14 Nishishimbashi 1-chome, Minato-ku,
Tokyo |
Capital |
: |
5,438 million yen (as of September
30, 2000) |
CEO |
: |
Noriaki Higuchi, President |
Employees |
: |
3,097 (consolidated basis, as of
September 30, 2000) |
Sales |
: |
725.3 billion yen (consolidated basis,
for fiscal year ended March 31, 2000) |
|
About Hitachi Medical Corporation
Hitachi Medical Corporation
manufactures, markets and services X-ray computerized tomography systems and MRI
systems, Hitachi Medical also handles domestic sales of clinical testing systems
developed and manufactured by the Instrument Group. |
|
Company Name |
: |
Hitachi Medical Corporation |
Head Office |
: |
1-14 Uchikanda 1-chome, Chiyoda-ku,
Tokyo |
CEO |
: |
Yutaka Takuma, President |
Capital |
: |
13,884 million yen (as of September
30, 2000) |
Employees |
: |
3,188 (consolidated basis, as of
September 30, 2000) |
Sales |
: |
109.5 billion yen (consolidated basis,
for the fiscal year ended March 31, 2000) |
|
About Instruments Group, Hitachi, Ltd.
CEO |
: |
Hiroshi Inomata, Senior Corporate
Officer |
Employees |
: |
3,886 (consolidated basis, as of September
30, 2000) |
Sales |
: |
116 billion yen (consolidated basis, for the fiscal
year ended March 31, 2000) |
About Semiconductor Manufacturing Equipment Group, Hitachi,
Ltd.
CEO |
: |
Toshihiro Sanematsu, Corporate
Officer |
Employees |
: |
380 (consolidated basis, as of September
30, 2000) |
Sales |
: |
26.5 billion yen (unconsolidated basis, for the fiscal
year ended March 31, 2000) |
|
WRITTEN BY Corporate Communications Division
|
|